SG11202105776WA - Imidazo[1,2-b]pyridazine il-17a inhibitors - Google Patents
Imidazo[1,2-b]pyridazine il-17a inhibitorsInfo
- Publication number
- SG11202105776WA SG11202105776WA SG11202105776WA SG11202105776WA SG11202105776WA SG 11202105776W A SG11202105776W A SG 11202105776WA SG 11202105776W A SG11202105776W A SG 11202105776WA SG 11202105776W A SG11202105776W A SG 11202105776WA SG 11202105776W A SG11202105776W A SG 11202105776WA
- Authority
- SG
- Singapore
- Prior art keywords
- imidazo
- pyridazine
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962789247P | 2019-01-07 | 2019-01-07 | |
| US201962842770P | 2019-05-03 | 2019-05-03 | |
| PCT/US2020/012115 WO2020146194A1 (en) | 2019-01-07 | 2020-01-03 | Imidazo[1,2-b]pyridazine il-17a inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105776WA true SG11202105776WA (en) | 2021-06-29 |
Family
ID=69423406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105776WA SG11202105776WA (en) | 2019-01-07 | 2020-01-03 | Imidazo[1,2-b]pyridazine il-17a inhibitors |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20220073526A1 (ja) |
| EP (1) | EP3908585B1 (ja) |
| JP (1) | JP7291226B2 (ja) |
| KR (1) | KR102600451B1 (ja) |
| CN (1) | CN113286795B (ja) |
| AU (1) | AU2020207196B2 (ja) |
| BR (1) | BR112021011095B1 (ja) |
| CA (1) | CA3125788C (ja) |
| CL (1) | CL2021001720A1 (ja) |
| CO (1) | CO2021008776A2 (ja) |
| CR (1) | CR20210357A (ja) |
| DO (1) | DOP2021000132A (ja) |
| EC (1) | ECSP21050201A (ja) |
| ES (1) | ES2977743T3 (ja) |
| IL (1) | IL284228B2 (ja) |
| JO (1) | JOP20210179A1 (ja) |
| MA (1) | MA54696A (ja) |
| MX (1) | MX2021008176A (ja) |
| PE (1) | PE20212304A1 (ja) |
| SA (1) | SA521422452B1 (ja) |
| SG (1) | SG11202105776WA (ja) |
| TW (2) | TWI752400B (ja) |
| WO (1) | WO2020146194A1 (ja) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11377425B1 (en) | 2018-12-19 | 2022-07-05 | Leo Pharma A/S | Small molecule modulators of IL-17 |
| WO2021222404A1 (en) | 2020-04-30 | 2021-11-04 | Janssen Biotech, Inc. | Imidazopyridazines as modulators of il-17 |
| MX2022015554A (es) | 2020-06-12 | 2023-01-30 | Leo Pharma As | Moduladores de molecula peque?a de interleucina 17 (il-17). |
| WO2021255085A1 (en) | 2020-06-18 | 2021-12-23 | Leo Pharma A/S | Small molecule modulators of il-17 |
| US20230227435A1 (en) | 2020-06-18 | 2023-07-20 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2021255086A1 (en) | 2020-06-18 | 2021-12-23 | Leo Pharma A/S | Small molecule modulators of il-17 |
| EP3943495A1 (en) | 2020-07-24 | 2022-01-26 | Leo Pharma A/S | Small molecule modulators of il-17 |
| CN113999234B (zh) * | 2020-07-28 | 2023-03-07 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| WO2022096411A1 (en) | 2020-11-09 | 2022-05-12 | UCB Biopharma SRL | Dicyclopropylmethyl derivatives as il-17 modulators |
| CN116406267A (zh) | 2020-11-09 | 2023-07-07 | Ucb生物制药有限责任公司 | 作为il-17调节剂的二环丙基甲基衍生物 |
| US20240140951A1 (en) | 2020-12-14 | 2024-05-02 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
| AR126255A1 (es) | 2021-07-01 | 2023-10-04 | UCB Biopharma SRL | Derivados de imidazotriazina como moduladores de il-17 |
| WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
| AU2022349687A1 (en) * | 2021-09-27 | 2024-05-16 | Janssen Pharmaceutica Nv | Imidazopyridazine il-17 inhibitor compounds |
| JP2024536863A (ja) * | 2021-09-27 | 2024-10-08 | ヤンセン ファーマシューティカ エヌ．ベー． | イミダゾピリダジンｉｌ－１７阻害剤化合物 |
| CN118103372A (zh) * | 2021-11-04 | 2024-05-28 | 西藏海思科制药有限公司 | 一种可抑制il-17a的杂环化合物及其用途 |
| WO2023111181A1 (en) | 2021-12-16 | 2023-06-22 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023166172A1 (en) | 2022-03-04 | 2023-09-07 | Leo Pharma A/S | Small molecule modulators of il-17 |
| CN114736104B (zh) * | 2022-04-20 | 2024-04-19 | 上海恩氟佳科技有限公司 | 一种二氟乙醛缩半乙醇的合成方法 |
| WO2023225664A1 (en) * | 2022-05-19 | 2023-11-23 | Dice Alpha, Inc. | Lactam substituted imidazopyridazine il-17a modulators and uses thereof |
| GB202210731D0 (en) | 2022-07-22 | 2022-09-07 | UCB Biopharma SRL | Therapeutic agents |
| WO2024115662A1 (en) | 2022-12-02 | 2024-06-06 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2024138286A1 (en) * | 2022-12-26 | 2024-07-04 | Usynova Pharmaceuticals, Ltd. | Il-17a modulators |
| WO2024163365A1 (en) * | 2023-01-30 | 2024-08-08 | Dice Alpha, Inc. | Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof |
| WO2024173173A1 (en) * | 2023-02-13 | 2024-08-22 | Dice Alpha, Inc. | Imidazotriazine il-17a modulators and uses thereof |
| WO2024201322A1 (en) * | 2023-03-28 | 2024-10-03 | Janssen Pharmaceutica Nv | Lactam-containing imidazopyridazine il-17 inhibitor compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702213D0 (en) * | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| WO2007013673A1 (en) * | 2005-07-29 | 2007-02-01 | Astellas Pharma Inc. | Fused heterocycles as lck inhibitors |
| WO2007104696A1 (en) * | 2006-03-15 | 2007-09-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Antimalarial agents having polyaromatic structure |
| EP2441768A1 (en) * | 2006-11-13 | 2012-04-18 | Eli Lilly & Co. | Thienopyrimidinones for treatment of inflammatory disorders and cancers |
| US9428511B2 (en) * | 2012-09-06 | 2016-08-30 | Bristol-Myers Squibb Company | Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
| WO2014066726A2 (en) | 2012-10-26 | 2014-05-01 | Ensemble Therapeutics Corporation | Compounds for modulating il-17 |
| UA112028C2 (uk) * | 2012-12-14 | 2016-07-11 | Пфайзер Лімітед | Похідні імідазопіридазину як модулятори гамка-рецептора |
| JP6458038B2 (ja) * | 2013-12-10 | 2019-01-23 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ＩＬ−１２、ＩＬ−２３および／またはＩＦＮα応答のモジュレーターとして有用なイミダゾピリダジン化合物 |
| JP6843135B2 (ja) * | 2015-11-18 | 2021-03-17 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ＩＬ−１２、ＩＬ−２３および／またはＩＦＮα応答のモジュレーターとして有用なイミダゾピリダジン化合物 |
-
2020
- 2020-01-02 TW TW109100073A patent/TWI752400B/zh active
- 2020-01-02 TW TW111100669A patent/TW202214648A/zh unknown
- 2020-01-03 WO PCT/US2020/012115 patent/WO2020146194A1/en unknown
- 2020-01-03 CR CR20210357A patent/CR20210357A/es unknown
- 2020-01-03 IL IL284228A patent/IL284228B2/en unknown
- 2020-01-03 JO JOP/2021/0179A patent/JOP20210179A1/ar unknown
- 2020-01-03 JP JP2021539549A patent/JP7291226B2/ja active Active
- 2020-01-03 AU AU2020207196A patent/AU2020207196B2/en active Active
- 2020-01-03 SG SG11202105776WA patent/SG11202105776WA/en unknown
- 2020-01-03 CA CA3125788A patent/CA3125788C/en active Active
- 2020-01-03 EP EP20703322.6A patent/EP3908585B1/en active Active
- 2020-01-03 KR KR1020217020765A patent/KR102600451B1/ko active IP Right Grant
- 2020-01-03 US US17/419,997 patent/US20220073526A1/en active Pending
- 2020-01-03 PE PE2021001117A patent/PE20212304A1/es unknown
- 2020-01-03 BR BR112021011095-0A patent/BR112021011095B1/pt active IP Right Grant
- 2020-01-03 CN CN202080008309.9A patent/CN113286795B/zh active Active
- 2020-01-03 ES ES20703322T patent/ES2977743T3/es active Active
- 2020-01-03 MA MA054696A patent/MA54696A/fr unknown
- 2020-01-03 MX MX2021008176A patent/MX2021008176A/es unknown
-
2021
- 2021-06-22 DO DO2021000132A patent/DOP2021000132A/es unknown
- 2021-06-25 CL CL2021001720A patent/CL2021001720A1/es unknown
- 2021-07-01 CO CONC2021/0008776A patent/CO2021008776A2/es unknown
- 2021-07-01 SA SA521422452A patent/SA521422452B1/ar unknown
- 2021-07-07 EC ECSENADI202150201A patent/ECSP21050201A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284228A (en) | imidazo[1,2-b]pyridazine il-17a inhibitors | |
| ZA201905456B (en) | Pyrrolo[1,2-b]pyridazine derivatives | |
| IL289462A (en) | Pyrazolo[4,3-b]pyrozine as shp2 phosphatase inhibitors | |
| IL276802A (en) | Transduced 2,1-dihydro-3h-pyrazolo[4,3-d]pyrimidin-3-ones | |
| IL280513A (en) | Imidazo[2,1-B]pyridazines as TRK inhibitors | |
| IL285315A (en) | Imidazo[1,2-f][4,2,1]triazine-4-amine derivatives as tlr7 agonists | |
| IL290445A (en) | [4,2,1]triazolo[5,1-c]quinazoline-5-amines | |
| ZA202100259B (en) | Pyrrolo[1,2-b]pyridazine derivatives | |
| EP3956322A4 (en) | JAK1 SELECTIVE KINAS INHIBITOR | |
| IL272988A (en) | Imidazo-[1,5-A]pyrazine derivatives as PI3K-delta inhibitors | |
| IL280122A (en) | Imidazo[2,1-B]pyridazine derivatives as TRK inhibitors | |
| EP3475286A4 (en) | USE OF PYRROLO [2,3-D] PYRIDAZIN-4-ONES AND PYRAZOLO [3,4-D] PYRIDAZIN-4-ONES COMPOUNDS SUBSTITUTED AS INHIBITORS OF PROTEIN KINASES | |
| IL279156A (en) | History of hexahydropyrrolo[4,3-C]pyrrole useful as LOX inhibitors |